ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

ISAVUCONAZOLUM

Active substance (INN) · ATC J02AC05 · 3 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
J02AC05	ISAVUCONAZOLUM	In force	medicine of the protocol	A forme orale,C1-G10-forme orale,C2- P9.1-P9.6, P9.7-forme orale, C3-forme orale	YES

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
CRESEMBA 100 mg	CAPS.	100mg	BASILEA PHARMACEUTICA DEUTSCHLAND GMBH - GERMANIA	J02AC05	PRF
CRESEMBA 200 mg	PULB. PT. CONC. PT. SOL. PERF.	200mg	BASILEA PHARMACEUTICA DEUTSCHLAND GMBH - GERMANIA	J02AC05	PRF
CRESEMBA 40 mg	CAPS.	40mg	BASILEA PHARMACEUTICA DEUTSCHLAND GMBH - GERMANIA	J02AC05	PRF

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.